These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 17654147)
1. The effect of dosing vehicle on arsenic bioaccessibility in smelter-contaminated soils. Basta NT; Foster JN; Dayton EA; Rodriguez RR; Casteel SW J Environ Sci Health A Tox Hazard Subst Environ Eng; 2007 Jul; 42(9):1275-81. PubMed ID: 17654147 [TBL] [Abstract][Full Text] [Related]
2. Modification of an existing in vitro method to predict relative bioavailable arsenic in soils. Whitacre S; Basta N; Stevens B; Hanley V; Anderson R; Scheckel K Chemosphere; 2017 Aug; 180():545-552. PubMed ID: 28432891 [TBL] [Abstract][Full Text] [Related]
3. In vitro bioaccessibility and in vivo relative bioavailability in 12 contaminated soils: Method comparison and method development. Li J; Li K; Cui XY; Basta NT; Li LP; Li HB; Ma LQ Sci Total Environ; 2015 Nov; 532():812-20. PubMed ID: 26116410 [TBL] [Abstract][Full Text] [Related]
4. Arsenic bioaccessibility in CCA-contaminated soils: influence of soil properties, arsenic fractionation, and particle-size fraction. Girouard E; Zagury GJ Sci Total Environ; 2009 Apr; 407(8):2576-85. PubMed ID: 19211134 [TBL] [Abstract][Full Text] [Related]
5. Lead bioaccessibility in 12 contaminated soils from China: Correlation to lead relative bioavailability and lead in different fractions. Li J; Li K; Cave M; Li HB; Ma LQ J Hazard Mater; 2015 Sep; 295():55-62. PubMed ID: 25911623 [TBL] [Abstract][Full Text] [Related]
6. In vitro gastrointestinal bioavailability of arsenic in soils collected near CCA-treated utility poles. Pouschat P; Zagury GJ Environ Sci Technol; 2006 Jul; 40(13):4317-23. PubMed ID: 16856753 [TBL] [Abstract][Full Text] [Related]
7. Validation of the in vitro gastrointestinal (IVG) method to estimate relative bioavailable lead in contaminated soils. Schroder L; Basta NT; Casteel SW; Evans TJ; Payton ME; Si J J Environ Qual; 2004; 33(2):513-21. PubMed ID: 15074802 [TBL] [Abstract][Full Text] [Related]
8. Effect of phosphate amendment on relative bioavailability and bioaccessibility of lead and arsenic in contaminated soils. Li SW; Liu X; Sun HJ; Li MY; Zhao D; Luo J; Li HB; Ma LQ J Hazard Mater; 2017 Oct; 339():256-263. PubMed ID: 28654790 [TBL] [Abstract][Full Text] [Related]
9. Predicting lead relative bioavailability in peri-urban contaminated soils using in vitro bioaccessibility assays. Juhasz AL; Smith E; Weber J; Rees M; Kuchel T; Rofe A; Sansom L; Naidu R J Environ Sci Health A Tox Hazard Subst Environ Eng; 2013; 48(6):604-11. PubMed ID: 23442111 [TBL] [Abstract][Full Text] [Related]
10. Assessment of four commonly employed in vitro arsenic bioaccessibility assays for predicting in vivo relative arsenic bioavailability in contaminated soils. Juhasz AL; Weber J; Smith E; Naidu R; Rees M; Rofe A; Kuchel T; Sansom L Environ Sci Technol; 2009 Dec; 43(24):9487-94. PubMed ID: 20000545 [TBL] [Abstract][Full Text] [Related]
11. Variability associated with as in vivo-in vitro correlations when using different bioaccessibility methodologies. Juhasz AL; Smith E; Nelson C; Thomas DJ; Bradham K Environ Sci Technol; 2014 Oct; 48(19):11646-53. PubMed ID: 25157927 [TBL] [Abstract][Full Text] [Related]
12. Predicting arsenic relative bioavailability in contaminated soils using meta analysis and relative bioavailability-bioaccessibility regression models. Juhasz AL; Weber J; Smith E Environ Sci Technol; 2011 Dec; 45(24):10676-83. PubMed ID: 22059522 [TBL] [Abstract][Full Text] [Related]
13. Bioaccessible and non-bioaccessible fractions of soil arsenic. Whitacre SD; Basta NT; Dayton EA J Environ Sci Health A Tox Hazard Subst Environ Eng; 2013; 48(6):620-8. PubMed ID: 23442113 [TBL] [Abstract][Full Text] [Related]
14. Validation of the predictive capabilities of the Sbrc-G in vitro assay for estimating arsenic relative bioavailability in contaminated soils. Juhasz AL; Herde P; Herde C; Boland J; Smith E Environ Sci Technol; 2014 Nov; 48(21):12962-9. PubMed ID: 25310703 [TBL] [Abstract][Full Text] [Related]
15. Relative bioavailability and bioaccessibility and speciation of arsenic in contaminated soils. Bradham KD; Scheckel KG; Nelson CM; Seales PE; Lee GE; Hughes MF; Miller BW; Yeow A; Gilmore T; Serda SM; Harper S; Thomas DJ Environ Health Perspect; 2011 Nov; 119(11):1629-34. PubMed ID: 21749965 [TBL] [Abstract][Full Text] [Related]
16. Predicting oral relative bioavailability of arsenic in soil from in vitro bioaccessibility. Diamond GL; Bradham KD; Brattin WJ; Burgess M; Griffin S; Hawkins CA; Juhasz AL; Klotzbach JM; Nelson C; Lowney YW; Scheckel KG; Thomas DJ J Toxicol Environ Health A; 2016; 79(4):165-73. PubMed ID: 27029599 [TBL] [Abstract][Full Text] [Related]
17. Comparison of in vivo and in vitro methodologies for the assessment of arsenic bioavailability in contaminated soils. Juhasz AL; Smith E; Weber J; Rees M; Rofe A; Kuchel T; Sansom L; Naidu R Chemosphere; 2007 Oct; 69(6):961-6. PubMed ID: 17585998 [TBL] [Abstract][Full Text] [Related]
18. Bioaccessibility of arsenic in mine waste-contaminated soils: a case study from an abandoned arsenic mine in SW England (UK). Palumbo-Roe B; Klinck B J Environ Sci Health A Tox Hazard Subst Environ Eng; 2007 Jul; 42(9):1251-61. PubMed ID: 17654145 [TBL] [Abstract][Full Text] [Related]
19. Correlation of in vivo relative bioavailability to in vitro bioaccessibility for arsenic in household dust from China and its implication for human exposure assessment. Li HB; Li J; Juhasz AL; Ma LQ Environ Sci Technol; 2014 Dec; 48(23):13652-9. PubMed ID: 25365687 [TBL] [Abstract][Full Text] [Related]
20. As, Cd, and Pb relative bioavailability in contaminated soils: Coupling mouse bioassay with UBM assay. Zhu X; Li MY; Chen XQ; Wang JY; Li LZ; Tu C; Luo YM; Li HB; Ma LQ Environ Int; 2019 Sep; 130():104875. PubMed ID: 31200159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]